| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2015 | Identification of five driver gene mutations in patients with treatment-naive lung adenocarcinoma in Taiwan. | Hsu, KH; Ho, CC; Hsia, TC; Tseng, JS; Su, KY; Wu, MF; Chiu, KL; Yang, TY; Chen, KC; Ooi, H; Wu, TC; Chen, HJ; Chen, HY; Chang, CS; Hsu, CP; Hsia, JY; Chuang, CY; Lin, CH; Chen, JJ; Chen, KY; Liao, WY; Shih, JY; Yu, SL; Yu, CJ; Yang, PC; Chang, GC | PloS one 10(3), e0120852 | | | |
| 2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang, YH; Hsu, KH; Tseng, JS; Chen, KC; Su, KY; Chen, HY ; Chang, CS; Chen, JJ; Yu, SL; Chen, HW; Yang, TY; Chang, GC | Journal of thoracic disease 8(1), 86-92 | | | |
| 2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma. | Tseng, JS; Yang, TY; Chen, KC; Hsu, KH; Yu, CJ; Liao, WY; Tsai, CR; Tsai, MH; Yu, SL; Su, KY; Chen, JJ; Chen, HY; Chang, GC | OncoTargets and therapy 7, 799-805 | | | |
| 2015 | R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability | Chen, HY; Yu, SL; Ho, BC; Su, KY; Hsu, YC; Chang, CS; Li, YC; Yang, SY; Hsu, PY; Ho, H; Chang, YH; Chen, CY; Yang, HI; Hsu, CP; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Hsia, JY; Chuang, CY; Yuan, S; Lee, MH; Liu, CH; Wu, GI; Hsiung, CA; Chen, YM; Wang, CL; Huang, MS; Yu, CJ; Chen, KY; Tsai, YH; Su, WC; Chen, HW; Chen, JJ; Chen, CJ; Chang, GC; Yang, PC; Li, KC | JOURNAL OF CLINICAL ONCOLOGY 33(20), 2303-2310 | | | |
